SPDR S&P Biotech ETF (XBI) sees strength amid more deal headlines
Tweet
Share
E-mailSPDR S&P Biotech ETF (NYSE: XBI) sees strength amid more deal headlines. Today it's PFE/GBT. The sector ETF is up 1.7%
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Saudi Arabia Oil Pipeline Struck By Projectiles Thursday - CNN
- Equity risk premium falls to 2002 levels. What it means for stocks
- Colgate-Palmolive explores sale of Softsoap, Irish Spring brands
Create E-mail Alert Related Categories
ETFs, Trader TalkRelated Entities
Standard & Poor'sSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
